These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29520889)

  • 41. Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study.
    Hazzan R; Abu Ahmad N; Slim W; Mazen E; Neeman Z
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7522-7532. PubMed ID: 36314323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
    Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
    Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
    Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
    Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effect of artichoke leaf extract against paracetamol-induced hepatotoxicity in rats.
    El Morsy EM; Kamel R
    Pharm Biol; 2015 Feb; 53(2):167-73. PubMed ID: 25243875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.
    Holtmann G; Adam B; Haag S; Collet W; Grünewald E; Windeck T
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1099-105. PubMed ID: 14653829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
    Zhang PW; Chen FX; Li D; Ling WH; Guo HH
    Medicine (Baltimore); 2015 May; 94(20):e758. PubMed ID: 25997043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.
    Panahi Y; Valizadegan G; Ahamdi N; Ganjali S; Majeed M; Sahebkar A
    J Cell Biochem; 2019 Sep; 120(9):15989-15996. PubMed ID: 31168845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
    Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters.
    Qiang Z; Lee SO; Ye Z; Wu X; Hendrich S
    Phytother Res; 2012 Jul; 26(7):1048-52. PubMed ID: 22183827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
    J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study.
    Geier A; Eichinger M; Stirnimann G; Semela D; Tay F; Seifert B; Tschopp O; Bantel H; Jahn D; Marques Maggio E; Saleh L; Bischoff-Ferrari HA; Müllhaupt B; Dufour JF
    Scand J Gastroenterol; 2018 Sep; 53(9):1114-1120. PubMed ID: 30270688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis.
    Rangboo V; Noroozi M; Zavoshy R; Rezadoost SA; Mohammadpoorasl A
    Int J Hepatol; 2016; 2016():4030476. PubMed ID: 27293900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.